Karakas M - Search Results

1

Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101).

Karakas M, Jarczak D, Becker M, Roedl K, Addo MM, Hein F, Bergmann A, Zimmermann J, Simon TP, Marx G, Lütgehetmann M, Nierhaus A, Kluge S. Karakas M, et al. Biomolecules. 2020 Aug 11;10(8):1171. doi: 10.3390/biom10081171. Biomolecules. 2020. PMID: 32796765 Free PMC article.

2

Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.

Zeller T, Waldeyer C, Ojeda F, Schnabel RB, Schäfer S, Altay A, Lackner KJ, Anker SD, Westermann D, Blankenberg S, Karakas M. Zeller T, et al. Among authors: karakas m. Biomolecules. 2018 Jul 20;8(3):60. doi: 10.3390/biom8030060. Biomolecules. 2018. PMID: 30037035 Free PMC article.

3

Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.

Ruhe J, Waldeyer C, Ojeda F, Altay A, Schnabel RB, Schäfer S, Lackner KJ, Blankenberg S, Zeller T, Karakas M. Ruhe J, et al. Among authors: karakas m. Biomolecules. 2018 Aug 9;8(3):72. doi: 10.3390/biom8030072. Biomolecules. 2018. PMID: 30096922 Free PMC article.

4

Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction.

Sörensen NA, Dönmez G, Neumann JT, Nikorowitsch J, Rübsamen N, Blankenberg S, Westermann D, Zeller T, Karakas M. Sörensen NA, et al. Among authors: karakas m. Biomolecules. 2019 Mar 18;9(3):108. doi: 10.3390/biom9030108. Biomolecules. 2019. PMID: 30889909 Free PMC article.

5

Design and Rationale of the ERA-CVD Consortium PREMED-CAD-Precision Medicine in Coronary Artery Disease.

Shrivastava A, Marzolla V, Weidmann H, Caprio M, Tregouet DA, Zeller T, Karakas M. Shrivastava A, et al. Among authors: karakas m. Biomolecules. 2020 Jan 11;10(1):125. doi: 10.3390/biom10010125. Biomolecules. 2020. PMID: 31940748 Free PMC article.

6

Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.

Nikorowitsch J, Ojeda F, Lackner KJ, Schnabel RB, Blankenberg S, Zeller T, Karakas M. Nikorowitsch J, et al. Among authors: karakas m. Biomolecules. 2020 Mar 4;10(3):394. doi: 10.3390/biom10030394. Biomolecules. 2020. PMID: 32143410 Free PMC article. Clinical Trial.

7

The ACCOST-HH Trial.

Skurk C, Rottbauer W, Kessler M, Akin I, Kluge S, Burdelski C, Blankenberg S, Zeller T, Landmesser U, Karakas M. Skurk C, et al. Among authors: karakas m. Eur Heart J. 2020 Dec 1;41(45):4296-4298. doi: 10.1093/eurheartj/ehaa757. Eur Heart J. 2020. PMID: 33111142 No abstract available.

8

MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19.

Roedl K, Jarczak D, Fischer M, Haddad M, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Karakas M, Kluge S, Nierhaus A. Roedl K, et al. Among authors: karakas m. Biomarkers. 2021 Jul;26(5):417-424. doi: 10.1080/1354750X.2021.1905067. Epub 2021 Apr 5. Biomarkers. 2021. PMID: 33754916

9

Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study.

Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L. Simon TP, et al. Among authors: karakas m. J Clin Med. 2021 Apr 13;10(8):1667. doi: 10.3390/jcm10081667. J Clin Med. 2021. PMID: 33924637 Free PMC article.

10

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.

Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, Huberlant V, Schuerholz T, François B, Lascarrou JB, Beishuizen A, Oueslati H, Contou D, Hoiting O, Lacherade JC, Chousterman B, Pottecher J, Bauer M, Godet T, Karakas M, Helms J, Bergmann A, Zimmermann J, Richter K, Hartmann O, Pars M, Mebazaa A; AdrenOSS-2 study participants. Laterre PF, et al. Among authors: karakas m. Intensive Care Med. 2021 Nov;47(11):1284-1294. doi: 10.1007/s00134-021-06537-5. Epub 2021 Oct 4. Intensive Care Med. 2021. PMID: 34605947 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page